TY - JOUR
T1 - Testosterone deficiency in young men
T2 - Marked alterations in whole body protein kinetics, strength, and adiposity
AU - Mauras, Nelly
AU - Hayes, Valerie
AU - Welch, Susan
AU - Rini, Annie
AU - Helgeson, Kevin
AU - Dokler, Maryanne
AU - Veldhuis, Johannes D.
AU - Urban, Randall J.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 1998
Y1 - 1998
N2 - To investigate specific effects of androgens on whole body metabolism, we studied six healthy lean men (mean ± SEM age, 23.2 ± 0.5 yr) before and after gonadal steroid suppression with a GnRH analog (Lupron), given twice, 3 weeks apart. Primed infusions of [13C]leucine, indirect calorimetry, isokinetic dynamometry, growth factor measurements, and percutaneous muscle biopsies were performed at baseline (D1) and after 10 weeks of treatment (D2); each subject served as his own control. Testosterone concentrations were markedly suppressed after 10 weeks of treatment (D1, 535 ± 141 ng/dL; D2, 31 ± 9). Leucine's rate of appearance (index of proteolysis) was markedly suppressed after 10 weeks of hypogonadism (-13%; P = 0.01) as well as the nonoxidative leucine disposal, an index of whole body protein synthesis (-13%; P = 0.01) without any changes in plasma amino acid concentrations. All subjects studied after 10 weeks showed a decrease in fat- free mass, as measured by skinfold calipers and dual emission x-ray absortiometry scans (D1, 56.5 ± 2.9 kg; D2, 54.4 ± 2.5; P = 0.005), and an increase in percent fat mass (D1, 19.2 ± 2.5%; D2, 22.2 ± 2.5; P = 0.001). Rates of lipid oxidation decreased (-31%; P = 0.05) after treatment, with parallel changes in resting energy expenditure (-9%; P = 0.05). Mean and peak GH concentrations (measured every 10 min for 6 h) and GH production rates did not decrease after testosterone deficiency, with an actual increase in basal secretion (P < 0.02). Plasma insulin-like growth factor I (IGF-I) concentrations did not change significantly after 10 weeks of treatment (D1, 227 ± 44 μg/L; D2, 291 ± 60; P = 0.08). Isokinetic dynamometry of leg extensors at 60°and 180°/s was also decreased after 10 weeks of hypogonadism. Total ribonucleic acid (RNA) was isolated from muscle biopsy samples, and ribonuclease protection assays were performed using human complementary DNA clones for IGF-I, IGF-binding protein-4, myosin, and actin. Ten weeks after Lupron treatment, messenger RNA (mRNA) concentrations of IGF- I decreased significantly, whereas there was a trend toward higher IGF- binding protein-4 concentrations, with no change in myosin or actin mRNA concentrations. In conclusion, testosterone deficiency in young men is associated with a marked decrease in measures of whole body protein anabotism, decreased strength, decreased fat oxidation, and increased adiposity. These effects of testosterone deficiency are independent of changes in peripheral GH production and IGF-I concentrations, even though im IGF-I mRNA concentrations decrease. These data suggest a direct effect of androgens on whole body lipid and protein metabolism.
AB - To investigate specific effects of androgens on whole body metabolism, we studied six healthy lean men (mean ± SEM age, 23.2 ± 0.5 yr) before and after gonadal steroid suppression with a GnRH analog (Lupron), given twice, 3 weeks apart. Primed infusions of [13C]leucine, indirect calorimetry, isokinetic dynamometry, growth factor measurements, and percutaneous muscle biopsies were performed at baseline (D1) and after 10 weeks of treatment (D2); each subject served as his own control. Testosterone concentrations were markedly suppressed after 10 weeks of treatment (D1, 535 ± 141 ng/dL; D2, 31 ± 9). Leucine's rate of appearance (index of proteolysis) was markedly suppressed after 10 weeks of hypogonadism (-13%; P = 0.01) as well as the nonoxidative leucine disposal, an index of whole body protein synthesis (-13%; P = 0.01) without any changes in plasma amino acid concentrations. All subjects studied after 10 weeks showed a decrease in fat- free mass, as measured by skinfold calipers and dual emission x-ray absortiometry scans (D1, 56.5 ± 2.9 kg; D2, 54.4 ± 2.5; P = 0.005), and an increase in percent fat mass (D1, 19.2 ± 2.5%; D2, 22.2 ± 2.5; P = 0.001). Rates of lipid oxidation decreased (-31%; P = 0.05) after treatment, with parallel changes in resting energy expenditure (-9%; P = 0.05). Mean and peak GH concentrations (measured every 10 min for 6 h) and GH production rates did not decrease after testosterone deficiency, with an actual increase in basal secretion (P < 0.02). Plasma insulin-like growth factor I (IGF-I) concentrations did not change significantly after 10 weeks of treatment (D1, 227 ± 44 μg/L; D2, 291 ± 60; P = 0.08). Isokinetic dynamometry of leg extensors at 60°and 180°/s was also decreased after 10 weeks of hypogonadism. Total ribonucleic acid (RNA) was isolated from muscle biopsy samples, and ribonuclease protection assays were performed using human complementary DNA clones for IGF-I, IGF-binding protein-4, myosin, and actin. Ten weeks after Lupron treatment, messenger RNA (mRNA) concentrations of IGF- I decreased significantly, whereas there was a trend toward higher IGF- binding protein-4 concentrations, with no change in myosin or actin mRNA concentrations. In conclusion, testosterone deficiency in young men is associated with a marked decrease in measures of whole body protein anabotism, decreased strength, decreased fat oxidation, and increased adiposity. These effects of testosterone deficiency are independent of changes in peripheral GH production and IGF-I concentrations, even though im IGF-I mRNA concentrations decrease. These data suggest a direct effect of androgens on whole body lipid and protein metabolism.
UR - http://www.scopus.com/inward/record.url?scp=0031733473&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031733473&partnerID=8YFLogxK
U2 - 10.1210/jc.83.6.1886
DO - 10.1210/jc.83.6.1886
M3 - Article
C2 - 9626114
AN - SCOPUS:0031733473
SN - 0021-972X
VL - 83
SP - 1886
EP - 1892
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 6
ER -